Close Menu

NEW YORK – Danaher reported on Thursday morning that its sales grew more than 19 percent year over year during the second quarter of 2020, including a 54 percent jump in its Life Sciences segment.

For the three months ended July 3, the Washington DC-based conglomerate recorded $5.30 billion in total sales compared to $4.44 billion in the year-ago period. It beat the consensus Wall Street estimate of $4.95 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.